{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:09:49Z","timestamp":1753891789647,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Radiation therapy (RT) is a standard treatment for the local control of primary pelvic cancers (PPC), yet the risk of second corpus uteri cancer (SCUC) in PPC patients undergoing RT is still controversial. This study investigated the impact of RT on the risk of SCUC and assessed the survival outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We queried nine cancer registries for PPC cases in the Surveillance, Epidemiology, and End Results (SEER) database. The cumulative incidence of SCUC was analyzed using Cox regression and Fine\u2013Gray competing risk regression analysis. The Poisson regression analysis was employed to assess the standardized incidence ratios (SIRs) and radiation-attributed risk (RR) for SCUC. We evaluated the overall survival of patients with SCUC using the Kaplan\u2013Meier method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Receiving radiotherapy was strongly associated with a higher risk of developing SCUC for PPC patients in Fine\u2013Gray competing risk regression (No-RT vs. RT: adjusted HR = 1.77; 95% CI, 1.40\u20132.28; <jats:italic>p<\/jats:italic> &amp;lt; 0.001). The incidence of SCUC in PPC patients who received RT was higher than in the US general population (SIR, 1.66; 95% CI, 1.41\u20131.93; <jats:italic>p<\/jats:italic> &amp;lt; 0.05), but the incidence of SCUC in patients who did not receive RT was lower than with the US general population (SIR, 0.68; 95% CI, 0.61\u20130.75; <jats:italic>p<\/jats:italic> &amp;lt; 0.05). The dynamic SIR and RR for SCUC decreased with decreasing age at PPC diagnosis and decreased with time progress. In terms of overall survival, 10-year survival rates with SCUC after No-RT (NRT) and SCUC after RT were 45.9% and 25.9% (HR = 1.82; 95% CI, 1.46\u20132.29; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Radiotherapy for primary pelvic cancers is associated with a higher risk of developing SCUC than patients unexposed to radiotherapy. We suggest that patients with pelvic RT, especially young patients, should receive long-term monitoring for the risk of developing SCUC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.957608","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:34:55Z","timestamp":1664426095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Guanhua","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengchang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xishan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy oncology group 0126 prostate cancer trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2015.09.003","article-title":"Contemporary breast radiotherapy and cardiac toxicity","volume":"26","author":"Yeboa","year":"2016","journal-title":"Semin Radiat Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.817","article-title":"Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial","volume":"20","author":"Marijnen","year":"2002","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(03)00117-8","article-title":"Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer","volume":"29","author":"Maduro","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2012.05.007","article-title":"Late gastrointestinal and urogenital side-effects after radiotherapy\u2013incidence and prevalence. subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer","volume":"104","author":"Schmid","year":"2012","journal-title":"Radiother Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.05.008","article-title":"Does pelvic radiation increase rectal cancer incidence? - a systematic review and meta-analysis","volume":"68","author":"Rombouts","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.02.007","article-title":"Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis","volume":"123","author":"Warschkow","year":"2017","journal-title":"Radiother Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.04.028","article-title":"Long-term survival and risk of second cancers after radiotherapy for cervical cancer","volume":"69","author":"Ohno","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.05.016","article-title":"Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up","volume":"66","author":"Liauw","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.13929","article-title":"Assessment of secondary sarcomas among patients with cancer of the abdomen or pelvis who received combinations of surgery, radiation, and chemotherapy vs surgery alone","volume":"3","author":"Hird","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0496-3","article-title":"Multiple primary malignancies in patients with prostate cancer: Increased risk of secondary malignancies after radiotherapy","volume":"18","author":"Okajima","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12885-020-06960-9","article-title":"Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up","volume":"20","author":"Vuolukka","year":"2020","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.543","article-title":"Occurrence of second cancers in patients treated with radiotherapy for rectal cancer","volume":"23","author":"Birgisson","year":"2005","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw661","article-title":"Incidence of second tumors after treatment with or without radiation for rectal cancer","volume":"28","author":"Rombouts","year":"2017","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijrobp.2007.12.043","article-title":"Second primary cancer after radiotherapy for prostate cancer\u2013a seer analysis of brachytherapy versus external beam radiotherapy","volume":"72","author":"Abdel-Wahab","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.10.022","article-title":"Increased risk for second primary rectal cancer after pelvic radiation therapy","volume":"124","author":"Rombouts","year":"2020","journal-title":"Eur J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.0991","article-title":"Prostate brachytherapy and second primary cancer risk: A competitive risk analysis","volume":"29","author":"Hinnen","year":"2011","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181954c5b","article-title":"Radiation-associated endometrial cancer","volume":"113","author":"Kumar","year":"2009","journal-title":"Obstet Gynecol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0090-8258(87)90232-0","article-title":"Endometrial cancer following radiation therapy for cervical cancer","volume":"27","author":"Gallion","year":"1987","journal-title":"Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00234-5","article-title":"Development of endometrial cancer after radiation treatment for cervical carcinoma","volume":"101","author":"Pothuri","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/01443610211114","article-title":"Uterine papillary serous carcinoma after pelvic radiation therapy for cancer of the cervix","volume":"22","author":"Behtash","year":"2002","journal-title":"J Obstet Gynaecol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2000.010003253.x","article-title":"Uterine papillary serous carcinoma following radiation therapy for carcinoma of cervix: A case report","volume":"10","author":"Park","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.05.039","article-title":"Radiation-associated endometrial cancers are prognostically unfavorable tumors: A clinicopathologic comparison with 527 sporadic endometrial cancers","volume":"103","author":"Pothuri","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-198202000-00002","article-title":"Endometrial cancers occurring 10 or more years after pelvic irradiation for carcinoma","volume":"1","author":"Rodriguez","year":"1982","journal-title":"Int J Gynecol Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(74)90133-1","article-title":"Malignancy of the uterine corpus following irradiation therapy for squamous cell carcinoma of the cervix","volume":"119","author":"Fehr","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: A retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2020.04.21","article-title":"Sentinel lymph node biopsy in endometrial cancer: State of the art","volume":"9","author":"L. Della Corte","year":"2020","journal-title":"Transl Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.957608\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:34:57Z","timestamp":1664426097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.957608\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":30,"alternative-id":["10.3389\/fonc.2022.957608"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.957608","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"957608"}}